Unknown

Dataset Information

0

Highly conserved epitopes of DENV structural and non-structural proteins: Candidates for universal vaccine targets.


ABSTRACT: Dengue is a severe emerging arthropod borne viral disease occurring globally. Around two fifths of the world's population, or up to 3.9 billion people, are at a risk of dengue infection. Infection induces a life-long protective immunity to the homologous serotype but confers only partial and transient protection against subsequent infection caused by other serotypes. Thus, there is a need for a vaccine which is capable of providing a life- long protection against all the serotypes of dengue virus. In our study, comparative genomics of Dengue virus (DENV) was conducted to explore potential candidates for novel vaccine targets. From our analysis we successfully found 100% conserved epitopes in Envelope protein (RCPTQGE); NS3 (SAAQRRGR, PGTSGSPI); NS4A (QRTPQDNQL); NS4B (LQAKATREAQKRA) and NS5 proteins (QRGSGQV) in all DENV serotypes. Some serotype specific conserved motifs were also found in NS1, NS5, Capsid, PrM and Envelope proteins. Using comparative genomics and immunoinformatics approach, we could find conserved epitopes which can be explored as peptide vaccine candidates to combat dengue worldwide. Serotype specific epitopes can also be exploited for rapid diagnostics. All ten proteins are explored to find the conserved epitopes in DENV serotypes, thus making it the most extensively studied viral genome so far.

SUBMITTER: Verma M 

PROVIDER: S-EPMC7125761 | biostudies-literature | 2019 May

REPOSITORIES: biostudies-literature

altmetric image

Publications

Highly conserved epitopes of DENV structural and non-structural proteins: Candidates for universal vaccine targets.

Verma Mansi M   Bhatnagar Shradha S   Kumari Kavita K   Mittal Nidhi N   Sukhralia Shivani S   Gopirajan At Shruthi S   Dhanaraj P S PS   Lal Rup R  

Gene 20190208


Dengue is a severe emerging arthropod borne viral disease occurring globally. Around two fifths of the world's population, or up to 3.9 billion people, are at a risk of dengue infection. Infection induces a life-long protective immunity to the homologous serotype but confers only partial and transient protection against subsequent infection caused by other serotypes. Thus, there is a need for a vaccine which is capable of providing a life- long protection against all the serotypes of dengue viru  ...[more]

Similar Datasets

| S-EPMC8310119 | biostudies-literature
| S-EPMC8654742 | biostudies-literature
| S-EPMC9133333 | biostudies-literature
| S-EPMC3538841 | biostudies-literature
| S-EPMC7112349 | biostudies-literature
| S-EPMC4361635 | biostudies-literature
| S-EPMC10614775 | biostudies-literature
| S-EPMC4038473 | biostudies-literature
| S-EPMC6690779 | biostudies-literature
| S-EPMC7350000 | biostudies-literature